Xilio Therapeutics Inc (XLO)
1.07
+0.14
(+15.04%)
USD |
NASDAQ |
May 31, 16:00
1.06
-0.01
(-0.93%)
After-Hours: 20:00
Xilio Therapeutics Cash from Investing (Quarterly): 0.00 for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -0.316M |
| March 31, 2023 | -0.17M |
| December 31, 2022 | -0.509M |
| September 30, 2022 | -0.333M |
| Date | Value |
|---|---|
| June 30, 2022 | -0.771M |
| March 31, 2022 | -0.254M |
| December 31, 2021 | -0.378M |
| September 30, 2021 | -0.114M |
| June 30, 2021 | -0.438M |
| March 31, 2021 | -0.17M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.771M
Minimum
Jun 2022
--
Maximum
Sep 2023
-0.2656M
Average
-0.254M
Median
Mar 2022
Cash from Investing (Quarterly) Benchmarks
| Gilead Sciences Inc | -2.207B |
| FibroGen Inc | 51.28M |
| Avalo Therapeutics Inc | 0.356M |
| IGM Biosciences Inc | 8.651M |
| AEON Biopharma Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.50M |
| Cash from Financing (Quarterly) | 0.954M |
| Free Cash Flow | -53.87M |
| Free Cash Flow Per Share (Quarterly) | -0.3762 |
| Free Cash Flow Yield | -182.3% |